NMTCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
NEUROONE MEDICAL TECHNOLOGIES Corp
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.00+0.04 (+4.01%)
Close on Oct 19, 2026
- Market cap
- $8.74M
- P/E (TTM)
- –
- Dividend yield
- –
NEUROONE MEDICAL TECHNOLOGIES Corp revenue by segment
By business segment
By product or service
| Revenue | Q3 24 | % of revenue |
|---|---|---|
| Product Revenue [Member] | $163.55K | 19.8% |
| OneRF Product [Member] | $163.55K | 19.8% |
By region
From the segment and revenue-disaggregation notes of Neuroone Medical Technologies's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.